NCT05338060 - A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

January 30, 2026

Conditions

GastroEsophageal Cancer

Interventions

OTHER

prospective collection of surgical exudates (SEs)

prospective collection of surgical exudates (SEs) from patients who are hospitalized for post-operative recovery from esophagectomy or gastrectomy for gastroesophageal cancer

Trial Locations (1)

22031

Inova Schar Cancer Institute, Fairfax